Responses
Therapeutics/Prevention
Randomised controlled trial
Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches
Compose a Response to This Article
Other responses
No responses have been published for this article.